|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-05-2005
NEW ORLEANS (Reuters Health) - The results of a small study suggest that desmoteplase, an investigational clot-busting drug derived from vampire bat saliva, safely restores blood supply to the brain when administered up to 9 hours after a stroke occurs.
WASHINGTON (Reuters) - An advocacy group for U.S. retirees said on Friday that it won a court order barring the government from allowing companies to drop older retirees from health care coverage while retaining coverage for younger retired workers.
NEW YORK (Reuters Health) - People who have a tendency to worry or feel very stressed out may be more likely to develop Alzheimer's disease later in life, new research reports.
WASHINGTON (Reuters) - Merck & Co. Inc.'s painkiller Arcoxia offers a "marginal" advantage in gastrointestinal safety but seems "worse than" other pain drugs in terms of deaths and serious cardiovascular problems, U.S. regulatory staff said in documents released on Friday.
UNITED NATIONS (Reuters) - U.N. diplomats drafting an international treaty on the rights of the disabled debated a possible ban on the abortion of fetuses with disabilities in an emotional negotiating session that ended on Friday.
NEW YORK (Reuters Health) - A mix of dietary supplements including antioxidants and plant-based estrogens may slow the rise of a biomarker for prostate cancer progression in some men, preliminary research suggests.
NEW YORK (Reuters Health) - Treatment with high-dose steroids for multiple sclerosis and other disorders may impair long-term memory, according to a report in the medical journal Neurology. The good news is that mental functioning usually returns to normal a few days after stopping the drug.
WASHINGTON (Reuters) - A clinical trial for Novartis AG's experimental painkiller Prexige showed the risk of heart attack, stroke and death was "similar" to Merck & Co. Inc.'s now withdrawn Vioxx, U.S. regulatory staff said in documents released on Friday.
TOKYO (Reuters) - Japan confirmed Friday its first case of the human variant of mad cow disease after the death of a man believed to have contracted the fatal brain-wasting illness from eating infected beef in Britain.
NEW YORK (Reuters Health) - Sustained-release lithium may be an effective treatment for pathological gambling in patients with bipolar spectrum disorder, also referred to as manic depression, the results of a small study suggest.
|
|
